Author

Jesse M. Cedarbaum

Yale UniversityORCID 0000-0002-5146-8784Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

John Peter SeibyliD· 2 shared Andrew D. SiderowfiD· 1 shared Andrew SingletoniD· 1 shared Anthony RussoiD· 1 shared Arthur W. TogaiD· 1 shared Biqing ZhuiD· 1 shared Brit MollenhaueriD· 1 shared Caroline M. TanneriD· 1 shared

Activity by Year

2020-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

John Peter SeibylORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Myeloid-Driven Inflammation in Prodromal Parkinson's Disease

Yoshiaki Yasumizu, M. Elizabeth Deerhake, Jeonghyeon Moon, Nicholas Buitrago-Pocasangre, Anthony Russo, Haowei Wang, Biqing Zhu, John Peter Seibyl, Vijaya Reddy, Qianchang Wang, Karen J Neish, Maria Grazia Spillantini, David A Posner, Menna Ruth Clatworthy, Tomokazu S. Sumida, , David A. Hafler

The paper identifies increased myeloid-driven inflammation in the CNS of prodromal Parkinson's Disease patients, linking gut and CNS immune responses through shared T cell clones.

bioRxiv · May 16, 2025 · PreprintImmunology

Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression

Brit Mollenhauer, Mohammed Dakna, Niels Kruse, Douglas R Galasko, Tatiana Foroud, Henrik Zetterberg, Sebastian Schade, Roland G. Gera, Wenting Wang, Feng Gao, Mark A. Frasier, Lana M. Chahine, Christopher S. Coffey, Andrew Singleton, Tanya Simuni, , Danielle L. Graham

This paper validates serum neurofilament light chain (NfL) as a biomarker for Parkinson's disease progression, showing increased levels in PD patients compared to healthy controls and a longitudinal increase correlating with clinical severity.

Movement Disorders · Aug 15, 2020Peer-reviewedNeuroscience